Literature DB >> 2899268

Quinolones and multiresistant Plasmodium falciparum.

J M Midgley, D W Keter, J D Phillipson, S Grant, D C Warhurst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2899268     DOI： 10.1016/s0140-6736(88)92571-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Antimalarial drugs currently in development.

Authors:  W E Gutteridge
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

3.  Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo.

Authors:  W Raether; H Seidenath; J Hofmann
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

Review 4.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

5.  Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.

Authors:  D Salmon; P Deloron; C Gaudin; K Malhotra; J Lebras; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 6.  Newly documented antimicrobial activity of quinolones.

Authors:  Y X Furet; J C Pechère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.